- Journal
- MEDICINE
- Année
- 2018
- Volume
- 97
- Numéro
- 40
- Article
- e12558
- Mois
- OCT
- DOI
- 10.1097/MD.0000000000012558
Abstract
Introduction: Post-operative cognitive dysfunction (POCD) is frequent in patients older than 60 years undergoing major non-cardiac surgery, and increases both morbidity and mortality. Anesthetic drugs may exert neurotoxic effects and contribute to the genesis of POCD. The hypothesis of the POCD-ELA trial was that closed-loop target-controlled infusion of propofol and remifentanil could reduce the occurrence of POCD by decreasing the risk of excessive depth of anesthesia and the dose of anesthetic drugs. Methods and analysis: We designed a single-center, single-blind, randomized, controlled, parallel trial and aim to include 204 patients aged >60 years undergoing elective major non-cardiac surgery. Patients will be randomized to receive closed-loop versus manual target-controlled infusion of propofol and remifentanil guided by bispectral index monitoring. Cognitive assessment will be performed the day before surgery (baseline) and within 72hours after surgery, using a battery of validated neuropsychological tests. The primary outcome is the incidence of POCD within 72hours after surgery. POCD is defined as a Z-score value >1.96 for at least 2 different tests or a Z-score composite value > 1.96. The calculation of the Z-score is based on data from an age-matched control population who did not undergo surgery or general anesthesia. Ethics and dissemination: This study was approved by the Ethics Committee (Comite de Protection des Personnes Est-II) and authorized by the French Health Products Agency (Agence Nationale de Securite des Medicaments, Saint-Denis, France). The University Hospital of Besancon is the trial sponsor and the holder of all data and publication rights. Results of the study will be submitted for publication in a peer-review international medical journal and for presentation in abstract (oral or poster) in international peer-reviewed congresses.